Blog
After Plummeting Over 30%, Are Arcturus Therapeutics Shares Still a Good Buy?
Arcturus Therapeutics' (NASDAQ: ARCT) stock saw deep losses on May 27, in part because of spillover from news about patients in Moderna's (NASDAQ: MRNA) COVID-19 vaccine trial experiencing adverse
3 Cannabis Stocks to Avoid Like the Plague in June
For years, marijuana stocks were viewed by investors as the greatest thing since sliced bread. With the legal pot industry generating $10.9 billion in worldwide sales in 2018, and Wall Street
3 Factors in Determining Your Ideal Retirement Age
Choosing the age at which you finally retire is one of the most important decisions you'll make, but it can be a difficult question to answer.
What you don't want to do is pick an age that sounds
Why Aurora Cannabis Stock Soared 59% in May
Shares of Aurora Cannabis (NYSE: ACB) surged 59% last month, according to data provided by S&P Global Market Intelligence. The marijuana producer delivered better-than-expected third-quarter results
Could This Obscure Biotech Stock Make Early Investors a Fortune?
Plenty of promising biotech stocks on the market right now have slipped under the radar thanks to the COVID-19 pandemic. Akero Therapeutics (NASDAQ: AKRO) is one such company. Founded back in 2017
Is Berkshire Hathaway a Buy While It's Down?
The stock market has rebounded nicely. After plunging by about 40% from its record highs in March as the COVID-19 pandemic worsened, the S&P 500 is now about 5% shy of where it started the year.
One
Why LivePerson Shares Rose 56% Last Month
Shares of LivePerson (NASDAQ: LPSN) gained 56.4% in May 2020, according to data from S&P Global Market Intelligence. The maker of AI-powered chatbots and highly automated business communication
Zynga Doubles Down on the Future With $1.8 Billion Acquisition
Zynga (NASDAQ: ZNGA) has been very successful in recent years using acquisitions to fuel its revenue growth. Since 2011, Zynga has spent billions on these acquisitions, typically with small-size
Better Buy: Bristol Myers Squibb vs. Gilead Sciences
There are few names more well-known in the biopharmaceutical world than Bristol Myers Squibb (NYSE: BMY) and Gilead Sciences (NASDAQ: GILD). While neither stock was immune to the coronavirus bear
3 Tricks to Help You Save on Your Taxes for Next Year
I know: You probably have a lot on your mind and don't want to think about taxes until you absolutely have to. But it's actually to your benefit to start thinking about your 2020 taxes now, even if
3 ETFs Perfect for Your IRA
Legendary investor Warren Buffett has said several times that the best way for the average American to invest isn't to buy individual stocks, but to simply invest in low-cost, passive index funds
Biotech Stocks: Buy This, Not That
A crucial aspect of success in investing in biotech stocks is that of timing. Buying a stock too early can mean enduring infinite dilution and clinical trial failures before a company can finally
2 Bargain Stocks You Can Buy Today
The stock market has rallied sharply since crashing in March. Although the S&P 500 was down by roughly 40% from all-time highs at the depths of the plunge, it is now within shouting distance of
Could the Rush to a Vaccine Hurt Coronavirus Stocks?
Nearly 6.2 million people worldwide are confirmed to have contracted COVID-19, more than 376,000 people have died, and the pandemic is far from over. So with containment of the coronavirus pandemic
Unemployed Due to COVID-19? Here's How It Could Affect Your Social Security Benefits
In April, the U.S. unemployment rate reached 14.7%, its worst on record since the Great Depression. And while May data hasn't been released as of this writing, it's safe to say that we have a
Here's Why Livongo Health Rocketed 49.8% Higher in May
Shares of Livongo Health (NASDAQ: LVGO), a digital health company, jumped 49.8% in May, according to data from S&P Global Market Intelligence. A glowing first-quarter earnings report provided
3 Top E-Commerce Stocks to Buy in June
There's little doubt that the trend toward e-commerce had taken hold long before COVID-19 reared its ugly head, but there's overwhelming evidence that the trend has experienced significant
Buffett's Portfolio Hasn't Done This in 4 Years, Until Now
For the past five-plus decades, Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett has been in a class of his own on the investing front. According to Berkshire Hathaway's annual
This is the Single Biggest Retirement Savings Mistake You Can Make
Saving enough to retire can seem difficult, especially during these financially turbulent times. Unfortunately, many people make it harder than it needs to be with a costly mistake: waiting to start
Zoom Stock Keeps Skyrocketing Higher
Shares of videoconferencing company Zoom Video Communications (NASDAQ: ZM) jumped higher on Wednesday, climbing about 8%. The stock's gain adds to a torrid year-to-date run-up. Shares are now up
Better Buy: Disney vs. Chipotle
Comparing Disney (NYSE: DIS) and Chipotle Mexican Grill (NYSE: CMG) might seem like comparing apples and oranges, but from an investment perspective, it doesn't make a difference. I consider both
Elastic N V (ESTC) Q4 2020 Earnings Call Transcript
Image source: The Motley Fool.
Elastic N V (NYSE: ESTC)Q4 2020 Earnings CallJun 03, 2020, 5:00 p.m. ET
Operator
Source Fool.com
Smartsheet Inc (SMAR) Q1 2020 Earnings Call Transcript
Image source: The Motley Fool.
Smartsheet Inc (NYSE: SMAR)Q1 2020 Earnings CallJun 3, 2020, 4:30 p.m. ET
Operator
Source Fool.com
Cloudera, Inc. (CLDR) Q1 2021 Earnings Call Transcript
Image source: The Motley Fool.
Cloudera, Inc. (NYSE: CLDR)Q1 2021 Earnings CallJun 3, 2020, 5:00 p.m. ET
Operator
Source Fool.com
Why Ubiquiti Stock Rose 13.8% in May
Shares of Ubiquiti (NYSE: UI) rose 13.8% during the month of May, according to data from S&P Global Market Intelligence. The networking equipment vendor delivered a better-than-expected earnings


